Research Catalog

Staff report on Sanofi's strategic use of third parties to influence the FDA /

Title
Staff report on Sanofi's strategic use of third parties to influence the FDA / prepared by the staff of the Committee on Finance, United States Senate.
Publication
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2011.

Items in the Library & Off-site

Filter by

1 Item

StatusFormatAccessCall NumberItem Location
Request for On-site UseRequest Scan
Not available - Please for assistance.
TextUse in library Y 4.F 49:S.PRT.112-20Off-site

Details

Additional Authors
United States. Congress. Senate. Committee on Finance. http://id.loc.gov/authorities/names/n78088975
Description
iii, 177 p.; 24 cm.
Series Statement
S. prt. ; 112-20
Uniform Title
S. prt. ; 111-20.
Subject
  • Anticoagulants (Medicine) > Government policy > United States
  • Drug approval > Corrupt practices > United States
  • Generic drugs > Government policy > United States
  • Sanofi aventis (Firm) > Corrupt practices
  • United States. Food and Drug Administration > Management
Note
  • At head of title: 112th Congress, 1st session. Committee print.
  • Shipping list no.: 2011-0375-P.
  • "May 2011."
  • Congressional Hearings may be available in digital format from Lexis-Nexis Congressional.
Bibliography (note)
  • Includes bibliographical references.
ISBN
  • 9780160890345
  • 0160890349
Owning Institutions
Princeton University Library